TNBC is generally regarded as a clinically aggressive subtype that typically occurs in young women and requires auxiliary chemotherapy to improve survival.23 Compared with hormone receptor-positive subtypes of BC, TNBC exhibits a different recurrence pattern. The gene discussed is NR4A1; the disease is breast cancer.